Our data show that SIRT6 reduces hepatic FFA, FC and p53 levels and apoptosis, partially explaining how hepatocyte SIRT6 inhibits NASH development. This evidence concerns the gene SIRT6 and metabolic dysfunction-associated steatohepatitis.